BUSINESS● LOWAug 13 · Aug 13, 2026, 12:34 PM
Ovid Therapeutics GAAP EPS of -$0.08 beats by $0.04, revenue of $73M
Seeking Alpha Tech
Ovid Therapeutics reported GAAP EPS of -$0.08, beating estimates by $0.04, and revenue of $73M. This shows the company's financial results surpassed expectations.
GlobeAlert aggregates and classifies open sources; the story above belongs to its publisher. Summaries are machine-generated from the source text.
More in Business
BUSINESSnowMunicipal Securities Underwriters Pay a Total of $325,000 in FinesSECBUSINESSnowSEC CHAIRMAN ARTHUR LEVITT, IOWA OFFICIALS TO HOLD INVESTORS’ TOWN MEETING IN DES MOINESSECBUSINESS18m agoN4,000/$ Exchange Rate: NDC asks why refineries are not workingVanguard NigeriaBUSINESS23m agoAt 50: Brand refresh raises questions about heritage, consumer loyaltyVanguard Nigeria